A41
Conditions
Interventions
Group 1: This cohort study is designed to investigate the clinical utility of an innovative biomarker panel for the early identification of patients with sepsis in acute settings. Early blood samples
Sponsors
Universitätsklinikum Jena
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Glasgow Coma Scale <15, respiratory rate = 22 / min, systolic blood pressure = 100 mmHg
Exclusion criteria
Exclusion criteria: Known pregnancy, acute myocardial infarction, leading traumadiagnosis, patients with therapy with limited life expectancy <28 days, already participants of the study with pre-stay
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Occurrence of sepsis within 96 hours | — |
Secondary
| Measure | Time frame |
|---|---|
| Septic shock within 96h, hospital / 28 day mortality, infection focus, microbiological examination results, organdysfunction, organs replacement, clinical and laboratory findings and medication during inpatient stay, transfer to ITS, ITS days, KH days, maximum SOFA score | — |
Countries
Germany
Contacts
Public ContactJohannes Winning
Universitätsklinikum JenaKlinik für Anaesthesiologie und Intensivmedizin
Outcome results
None listed